interferon-gamma (IFNg) [12] . Furthermore, IL-12 is known to be involved in infectious and organ specific autoimmune diseases [6, 7, 13, 14] . The p40 subunit is able to form a homodimer, which has been shown to antagonize IL-12 activities in vitro and hence may reflect a natural suppressor of Th1 activation in vivo [15, 16] . In our present study we examined the inhibitory effect of the IL-12 antagonist IL-12 (p40) 2 on the development of the CY accelerated diabetes of the NOD mice in vivo.
Materials and methods
Animals. Female NOD/Bom mice were purchased from Bomholtgard Breeding Centre (Ry, Denmark) at 9 weeks of age and maintained in our animal facility under conventional conditions with standard diet (Sniff, Soest, Germany) and tap water ad libitum (mean incidence: 0 % at age 80 days, > 90 % at age 250 days). One group of animals (n = 31) was treated daily with 0. All mice received CY (250 mg/kg i. p.) at 70 days of age. Urinary glucose analysis was performed daily starting 8 days after CY treatment and hyperglycaemia was confirmed by blood glucose determination. Animals were regarded as diabetic when blood glucose levels were found to be above 16.7 mmol/l as determined by the hexokinase method. Groups of 5-6 normoglycaemic animals were killed before and 10 days after injection of CY. The later point of time is close to the onset of overt diabetes in a fraction of mice (Fig. 1 ). Mice were killed under anaesthesia, the pancreas was excised and cut in half longitudinally for histological and mRNA analysis. The principles of laboratory animal care were followed (NIH publication No. 85-23, revised 1985).
IL-12 homodimer. IL-12(p40) 2 was generously provided by E. Nickbarg (Genetics Institute, Cambridge, Mass., USA). Purified IL-12(p40) 2 was prepared as described previously [16] and was essentially free (> 98 %) of p40 monomer. mRNA analysis. Total RNA was isolated from fresh pancreatic tissue by guanidinium thiocyanate-phenol-chloroform extraction [3] . Isolated RNA quality was verified by running a 1.2 % agarose gel with 4 % formaldehyde. All isolated RNA showed intact 18 S and 28 S rRNA bands without visible degradation of the mRNA, like total RNA of spleens which was always isolated in parallel. Determination and quantification of specific mRNA was performed by reverse transcriptase polymerase chain reaction (RT-PCR) as described elsewhere [3, 18] . Specific primers for b -actin, IFN-g, IL-4, IL-10 and TGF-b were purchased from Clontech (Clontech Laboratories Inc., Palo Alto, Calif., USA). The specific primers for inducible nitric oxide synthase (iNOS), IL-12 p40 and IL-12 p35 were used as described elsewhere [3, 5] . The first cycle of each PCR was started for 3 min at 95°C denaturation time. In the next cycles denaturation was performed for 1 min. Primer annealing was done for Isolation and stimulation of peritoneal macrophages. Peritoneal macrophages were isolated by lavage of the peritoneum with 4-ml ice-cold HBSS (Hank's balanced salt solution; Gibco, Heidelberg, Germany). The cells were washed three times with 10 ml PBS (Gibco) and separated by adherence on FCS (fetal calf serum, Gibco) coated petri dishes (37°C, 5 % CO 2 ). After 1 h the non-adherent cells were flushed off and the adherent cell population was detached by incubation for 7 min in ice-cold Ca 2 + -Mg 2 + -free HBSS. The detached cells were washed three times in ice-cold PBS, resuspended in RPMI 1640 + 10 % FCS at 10 6 /ml, followed by culture in 12-well microtiter wells. The cells were stimulated with 1 m g lipopolysaccharide (LPS from Salmonella minnesota, Sigma) for 0, 24 h.
Nitrite and TNF production by macrophages. Supernatants of the macrophage cultures were collected and nitrite levels were determined by the Griess method as described previously [19] . In the same supernatants TNFa levels were measured by a L929 bioassay [20] .
Histology. Pancreatic tissue was snap frozen in liquid nitrogen and cryostat sections were stained with haematoxylin-eosin for evaluation of infiltrating immune cells by light microscopy. Analysis was done for all islets in different sections at intervals of 100 m m, yielding a total of at least 20 islets per animal. Three grades of infiltration were defined: grade 1: no periductular infiltrates or less than 5 immune cells peri-and intra-insular with or without periductular infiltrates; grade 2: periductular and peri-insular infiltrates with or without intra-islet infiltration of less than 20 % of the islet area; grade 3: intra-islet infiltration of more than 20 % of the islet area. Slides were coded and insulitis grades rated independently by two observers. 
Results
Treatment of NOD mice with CY induced overt diabetes in 27 of 59 mice (Fig. 1 ). All cases of diabetes occurred during days 8-13 after CY, demonstrating synchronization of the disease process. NOD mice treated daily with IL-12(p40) 2 showed suppression of diabetes incidence (p < 0.05, Fig. 1 ).There was no delay of diabetes development in the IL-12(p40) 2 treated mice compared to the control group. Prior to CY administration NOD mice were devoid of insulitis in the majority of islets (Table 1) . Substantial progression of insulitis was seen 10 days after CY treatment in normoglycaemic mice. Nearly all islets exhibited an advanced insulitis grade with intra-islet infiltration (97 %, p < 0.0001 compared to day 0). In the IL-12(p40) 2 treated group progression of insulitis towards intrainsular infiltration was also noted, but it was less pronounced 10 days after CY treatment, with 25 % rather than 3 % of islets with grades 1-2 (p < 0.001 compared to animals treated with CY alone, Table 1 ).
Analysis of the cytokine mRNA expression pattern in these animals showed significant differences between the normoglycaemic IL-12(p40) 2 treated and control animals. The CY-treated control animals showed upregulated gene expression in the Th1 specific cytokine IFN-g. Treatment with IL-12(p40) 2 dampened the rise in IFN-g mRNA levels (p < 0.05, Fig. 2A ). Gene expression of the Th2 cytokine IL-10 Islet infiltration grades were analysed by eosin-haematoxylin staining of snap frozen pancreata was also induced by CY but mean mRNA levels were not significantly affected by administration with IL12p40 homodimer. The most striking effects were noted for the ratio of IFN-g compared to IL-10 mRNA levels. Treatment with IL-12(p40) 2 strongly decreased Th1/Th2 mRNA ratios (Fig. 2C, p < 0.01) .
The analysis of IL-12p35 and p40 mRNA is shown in Figure 3 . CY induced a fivefold increase of IL12p35 and an eightfold increase of IL-12p40 mRNA. Concomitant administration of the IL-12 antagonist decreased p35 mRNA levels (p < 0.05) but did not affect p40 mRNA levels. Next, the ratio of IL-12p40 compared to p35 mRNA levels of individual animals was calculated. The group treated with IL-12 antagonist had a lower p35/p40 ratio (p < 0.05).
We also examined the mRNA expression of the iNOS as a parameter closely associated with betacell destruction [3, 17] . INOS mRNA expression increased after CY treatment in both animal groups, but there was significantly less iNOS mRNA expression in the IL-12(p40) 2 treated animal group (Fig. 4A, p < 0.05) . Animals with high iNOS expression also showed a high ratio of Th1 over Th2 cytokine expression (Fig. 4B) . The correlation between iNOS mRNA levels and the ratio IFN-g/IL-10 mRNA was calculated as R = 0.98, p < 0.05.
Finally, we tested wether administration of IL-12(p40) 2 
Discussion
Administration of IL-12(p40) 2 significantly decreased the incidence of CY-induced diabetes. It is probable that this effect is due to the inhibitory effect of the p40 homodimer on IL-12 functions as shown in vitro [15] . During preparation of this manuscript, parallel work by Trembleau et al. [21] has been published in abstract form which also describes an inhibitory effect of IL-12(p40) 2 on the disease process in NOD mice. IL-12(p40) 2 acts as a specific antagonist by binding to the IL-12 receptor without inducing appropriate signals [16, 22] . If exogenous IL-12(p40) 2 exhibited similar properties in vivo, effects on IL-12 driven IFN-g production and the Th1/Th2 cytokine balance are to be expected. Previous studies linked a shift towards Th1 dominated insulitis with progression from benign towards destructive insulitis and subsequent diabetes onset. We therefore analysed mice before and after CY-accelerated progression towards Th1 insulitis. Indeed, we observed less IFN-g gene expression and a decreased IFN-g/IL-10 mRNA ratio in the pancreas of NOD mice receiving injections of p40 homodimer in addition to CY.
Cytokine gene expression was analysed in total pancreas RNA because islet isolation in our hands introduces a bias due to poor islet yield in animals with advanced stages of insulitis and the preferential loss of periductular and peri-insular over intra-islet leukocytes during the isolation procedure. Previous studies have shown a close correlation between pancreatic mRNA levels and immunostaining of cytokines in islet sections [3] . In addition, we observed a close correlation between cytokine mRNA levels in total pancreas with the mean insulitis score in individual animals [18] in another animal model of spontanous diabetes development, the BioBreeding rat.
We conclude that exogenous IL-12(p40) 2 interfered with activation of Th1 immune reactivity in the pancreas of CY-treated NOD mice, leading to dampening of Th1-dependent destructive insulitis. The conclusion concurs with results of semiquantitative grading of insulitis which shows a significant decrease of intra-islet infiltration in mice receiving IL-12(p40) 2 .
The lesser aggressiveness of the insulitis process in mice treated with the IL-12 antagonist is also recognizeable from a significantly decreased expression of iNOS mRNA. INOS mRNA is induced in macrophages, endothelial cells and beta cells by inflammatory cytokines such as IFN-g , IL-1 and TNFa, while Th2 cytokines are inhibitory [23] [24] [25] . A close correlation between pancreatic iNOS mRNA levels and destructive intra-islet infiltration has been reported by our group [3, 18] . An interrelationship between the cytokine network and iNOS gene expression is demonstrated here by a significant correlation of individual iNOS mRNA levels with the IFN-g/IL-10 mRNA ratio in pancreatic RNA. A causal relationship between IFN-g/IL-10 mRNA ratio and iNOS expression seems probable. Studies in vitro and in vivo have shown that IFN-g induces iNOS expression while IL-10 is suppressive [26, 27] . Nitric oxide is regulated as a mediator of beta-cell destruction in rodent models of type 1 diabetes [28, 29] . In addition, iNOS expression is a marker of macrophage activation. Taken together, the decreased expression of iNOS mRNA in the pancreas of NOD mice receiving IL-12(p40) 2 indicates a dampening of the diabetogenic inflammatory process.
Interestingly, the administration of IL-12(p40) 2 also acted back on IL-12 gene expression. While levels of p40 mRNA remained unaffected there was significant suppression of p35 gene expression. The p35 subunit of the bioactive heterodimer appears to mediate much of the signalling in terms of inducing IFN-g production in IL-12 receptor positive Th1 or Th0 cells [30, 31] . Hence, the downregulation of p35 message in reponse to IL-12(p40) 2 treatment indicates a decrease of bioactive IL-12 in NOD mouse pancreas. This regulatory action of the p40 homodimer on p35 gene expression may result from a direct effect on macrophages or may be a consequence of decreased Th1 reactivity and the resulting lower IFN-g/IL-10 ratio. IFN-g is a potent inducer, IL-10 is a suppressor of IL-12 production [32] . However, IL-10 has been reported to suppress both p35 and p40 gene transcription [33] , which has not been observed here. We conclude that the IL-12 antagonist not only competes with bioactive IL-12 for Th1 cell activation but also suppresses further release of IL-12 inhibiting IL-12p35 gene transcription.
Our studies render an in vivo role of the p40 homodimer in regulating IL-12 bioactivity and Th1 responses possible. Further support has come from a pilot trial of IL-12(p40) 2 treatment in collagen arthritis of mice, where a delay of clinical symptoms and a decrease of disease incidence was noted [34] . A role for IL-12(p40) 2 as a natural antagonist of IL-12 in vivo is also supported by reports that p40 is produced in excess over IL-12 [32] [33] [34] [35] and for longer periods than bioactive IL-12 is demonstrable [36, 37] . In situ hybridization of spleens of LPS-injected mice showed that most of the p35 and p40 mRNA is localized in different areas [38] . Naturally occurring p40 homodimer has been purified and shown to inhibit IL-12-induced T-cell proliferation.
In conclusion, we have shown that exogenous IL-12(p40) 2 represents a new and specific approach to interfere with the development of IL-12 dependent autoimmune type 1 diabetes. Since IL-12(p40) 2 also occurs naturally, treatment with this IL-12 antagonist probably makes use of physiological feedback mechanisms to restrict Th1 reactivities. Furthermore, the decreased expression of iNOS in the pancreata of IL-12(p40) 2 treated mice indicates a lower activation stage of macrophages and other inflammatory cells, which will promote beta-cell survival.
